Atara Biotherapeutics Inc (NASDAQ:ATRA)

5.22
Delayed Data
As of 3:59pm ET
 +0.35 / +7.19%
Today’s Change
4.61
Today|||52-Week Range
20.04
-66.88%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Atara Biotherapeutics Inc have a median target of 23.50, with a high estimate of 67.00 and a low estimate of 4.00. The median estimate represents a +350.19% increase from the last price of 5.22.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Atara Biotherapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.79
Sales
$7.0M
Reporting Date
Aug 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.46%
 
 
 
 
 
 
Growthannually 9.21%
 
 
 
 
 
 

Sales

Growthquarterly -4.07%
 
 
 
 
 
 
Growthannually 174.12%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.